SCHEMBL9213710

SCHEMBL9213710

Cc1c(C)c2cc(Cl)c(OCC3CN(C(=O)OC(C)(C)C)CCO3)cc2oc1=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 6/20 0.49
▸ EPHB4 P54760 2/20 0.49
▸ ERBB2 P04626 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CSF1R P07333 1/20 0.39
▸ KDR P35968 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ P2RX3 P56373 3/20 0.38
▸ P2RX2 Q9UBL9 3/20 0.38
▸ BUB1 O43683 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ FHIT P49789 1/20 0.36
▸ DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9221753 0.81 KDM4E (0.54) EPHA2EPHB4ERBB2ALDH1A1HSD17B10
SCHEMBL9211090 0.81 KDM4E (0.54) EPHA2EPHB4ERBB2ALDH1A1HSD17B10
SCHEMBL4510923 0.77 EPHA2 (0.54) EPHA2EPHB4ERBB2DRD4
SCHEMBL9213959 0.76 EPHA2 (0.48) EPHA2EPHB4ERBB2ALDH1A1PKM
SCHEMBL28851224 0.75 EPHA2 (0.51) EPHA2EPHB4ERBB2ALDH1A1BUB1
SCHEMBL1700442 0.75 EPHA2 (0.51) EPHA2EPHB4ERBB2PKMKDR
SCHEMBL9214625 0.75 KDM4E (0.56) ALDH1A1MAPK1HSD17B10KDM4E
SCHEMBL22944175 0.75 EPHA2 (0.52) EPHA2EPHB4ERBB2KDRP2RX3
SCHEMBL9213901 0.74 ALDH1A1 (0.50) EPHA2EPHB4ALDH1A1PKMMAPK1
SCHEMBL19474639 0.74 EPHA2 (0.49) EPHA2EPHB4ERBB2CSF1RP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0411912-B1 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders SANKYO CO (JP) 1995-04-19 — — EP disclosed
EP-0411912-A2 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders Sankyo Company Limited (JP) 1991-02-06 — — EP disclosed
Send feedback